# Comparison of Ferrous Salt vs. Liposomal Iron in Adult Women With Iron-Deficiency Anemia

> **NCT07556731** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Hospital General de Mexico** · enrollment: 100 (estimated)

## Conditions studied

- Iron-deficiency Anemia (IDA)
- Hemoglobin
- Iron Deficiencies
- Adverse Effect

## Interventions

- **DRUG:** Oral ferrous fumarate administered every 24 hours
- **DRUG:** Ferrous fumarate administered orally every 48 hours.
- **DRUG:** Liposomal iron formulation.

## Key facts

- **NCT ID:** NCT07556731
- **Lead sponsor:** Hospital General de Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-05-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07556731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07556731, "Comparison of Ferrous Salt vs. Liposomal Iron in Adult Women With Iron-Deficiency Anemia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07556731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*